Delivery Order SPE2DB22D2206-SPE2DB24FGN88
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,087.68 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This contract is for the delivery of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, to be completed by February 13, 2024. Amerisourcebergen Drug Corp, as the prime contractor, has an existing indefinite delivery contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,417.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENDOCET 10-325 MG TABLET 100S. The contract has a potential value of $4,350.72 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this order, which falls under an existing indefinite delivery contract (IDC) with DLA valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,012.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,850.78, is for the delivery of 4,564,005,666 tablets of ENDOCET 10-325 MG, a prescription pain medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,586.03 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a medication used for pain management. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of the major pharmaceutical distribution company Amerisourcebergen Corporation, provides for the delivery of ENDOCET 10-325 MG TABLET 100S to the Department of Defense (DoD). The contract has a ceiling value of $2,719.20 and a completion date of June 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $1,104.56, this order is for the supply of 100 tablets of Endocet 10-325mg to the DLA place of performance in Conshohocken, Pennsylvania, with completion by October 31, 2023. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical product in support of DLA's provision of...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $1,132.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OxyContin ER 15 mg tablets. This contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $27,558.32 delivery order to AmerisourceBergen Drug Corp for Percocet tablets (10/325 mg) under a firm fixed-price contract. The award, announced on September 4, 2025, represents a competitive procurement with an ultimate completion date of September 5, 2025. This delivery order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. No set-aside...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGN88Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Endocet 10-325 mg tablets to support military treatment programs and facilities. The contract, valued up to $1,087.68, has a performance period through April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense. This latest award does not have a set-aside designation.
Generated 7/8/24, 9:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/8/24 |